Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis

February 1996

Rhone-Poulenc Rorer is now marketing Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

ALS is a progressive, degenerative disease of the nerves. It leads to muscle weakness...paralysis...and eventually death.

ALS is thought to be caused by excess glutamate...an excitatory neurotransmitter that causes nerve damage.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote